Recursion Pharmaceuticals, Inc. (RXRX)
3.46
-0.08
(-2.26%)
USD |
NASDAQ |
Mar 06, 16:00
3.455
0.00 (0.00%)
After-Hours: 20:00
Recursion Pharmaceuticals SG&A Expense (TTM) : 176.59M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Intellia Therapeutics, Inc. | 119.80M |
| Tango Therapeutics, Inc. | 31.74M |
| Hims & Hers Health, Inc. | 1.192B |
| Novavax, Inc. | 157.48M |
| Geron Corp. | 159.26M |